Navigation Links
Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results
Date:5/15/2009

ilities of $3.8 million on March 31, 2009. For the first nine months of 2009, the Company generated $4.4 million in cash from operations versus $1.8 million for the same period in 2008.

Business Development

On January 30, 2009, Tianyin began initial purchases under its previously announced stock repurchase program to buy back up to $3.0 million of its common stock. These shares will be retired to the treasury while reducing the number of outstanding common shares. As of March 31, 2009, 79,285 shares have been bought back at prevailing market prices.

During the third quarter of fiscal 2009, Tianyin adopted the "Cost Preference Strategy" for Azithromycin Dispersible Tablets which could yield over $3.7 million in incremental revenues on an annual basis in the future.

On March 26, 2009, Tianyin announced that the Board of Directors declared an annual cash dividend of $0.10 per common share that will be paid quarterly. On April 14, the majority of the Company's Series A Preferred Shareholders approved the cash dividend to common stockholders. The initial dividend of $.025 will be paid to common shareholders of record on April 30, 2009, with the actual distribution occurring on or about June 10, 2009. The decision was made so the company could provide its common shareholders with ongoing participation in company profits while ensuring that adequate capital was available for future growth.

During the quarter, Tianyin completed installing the steel framework and roofing of the new production facility with production expected to commence in the summer of 2009. The Company recently completed the construction and began testing its production line recently. The new plant will expand production capacity of solid dosage drugs by 300% and will be utilized to meet growing demand for the Company's current products, while also accommodating new product launches for those in the development p
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Viscorp, Inc. Announces Name Change to Tianyin Pharmaceutical Co Inc. and Begins Trading Under the Ticker OTC BB: TYNP
2. Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time
3. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2008 Third Quarter Earnings Conference Call on Thursday, May 15, 2008 at 9:00 a.m. EDT
4. Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2008 Financial Results
5. Tianyin Pharmaceutical Signs Over 60 New Distribution Agreements with 15 Regional Distributors
6. Tianyin Pharmaceutical Co., Inc. Completes Production for Earthquake
7. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Simvastatin Tablets
8. Tianyin Pharmaceutical Co., Inc. Announces Trading Symbol Error and Correction
9. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Laonian Kechuan Tablets
10. Tianyin Pharmaceutical Co., Inc. Authorizes $3.0 Million Stock Repurchase Program
11. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 First Quarter Earnings Conference Call on Tuesday, November 11, 2008 at 8:30 a.m. EST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2010)... for It Makes Little Sense , ... , , ... ... PRINCETON, N.J. ... ...
(Date:3/16/2010)... common sense behaviors, including having a discussion at home ... spread of H1N1 in a household, according to a ... in 2009. Published in the April 1 issue of ... is available online ( http://www.journals.uchicago.edu/doi/abs/10.1086/651145 ). , People with ... work or school, which is why scientists need to ...
(Date:3/16/2010)... cleaning products company, launched a new laundry detergent for U.S. ... – the Robby Wash ultra he detergent. The hypoallergenic laundry ... cleans for up to 12 months – replacing 75 lbs. ... over 200 washes. , ... Austin, ...
(Date:3/16/2010)... after the treatment, study found , , TUESDAY, March 16 ... of radiation therapy kept early-stage lung tumors stable in ... of patients who underwent the therapy, called stereotactic body ... their treatment, according to preliminary findings from a study ... Journal of the American Medical Association , a themed ...
(Date:3/16/2010)... winners of the Best Paper Awards for articles published ... during 2009. SEBM recognizes the best paper annually ... Research, Experimental Biology, and Interdisciplinary Research. The Interdisciplinary ... The first author of each Best Paper will receive ... in the journal and at the Society,s Reception at ...
Breaking Medicine News(10 mins):Health News:NJHA: Charity Care Must Be a Priority as Uninsured Burden Grows 2Health News:Preventive behaviors limited household transmission of H1N1 influenza during initial outbreak 2Health News:Preventive behaviors limited household transmission of H1N1 influenza during initial outbreak 3Health News:Oransi Launches Robby Wash High Efficiency Laundry Detergent in U.S. – 10 Ounces Replaces 75 lbs. of Traditional Laundry Detergent 2Health News:Oransi Launches Robby Wash High Efficiency Laundry Detergent in U.S. – 10 Ounces Replaces 75 lbs. of Traditional Laundry Detergent 3Health News:Radiation May Help Those With Inoperable Lung Tumors 2Health News:Radiation May Help Those With Inoperable Lung Tumors 3
... New computer software that will allow GPs to more accurately ... disease has been released for clinical use. , QRISK2 uses ... risk of developing the heart condition over the next 10 ... real primary care data from the UK. , The QRISK2 ...
... one click away and there,s a growing army of couples ... dubious beginnings four centuries ago the personal column has become ... partner. , Dr Harry Cocks, a lecturer in the ... published a book telling the story of how we finally ...
... -Hiawatha Community Hospital Implements IntelliDOT Barcode Point-of-Care Patient Safety ... provider of wireless, handheld barcode point-of-care (BPOC) solutions ... Medication Administration (TM) (IntelliDOT BMA(TM)) is now being used ... became the 55th customer to go live with ...
... program that focuses on similar practices used by ... -- The Partnership for Patient Care, a ... Pennsylvania hospitals and one of the region,s largest ... new initiatives for 2009-2011 today at a conference ...
... of patients with heart failure (HF) have problems with ... new study published by Elsevier, in the February issue ... ). , Memory problems and other cognitive deficits ... medical care for patients with HF, according to the ...
... is the first news organization to receive an ... Foundation for Informed Medical Decision Making. The Foundation, which ... Forum in Washington DC, chose the Milwaukee newspaper because ... That web-based project, funded by the Foundation, is the ...
Other Medicine News:Health News:New GP computer software to help prevent heart disease 2Health News:Classified -- the lonely heart's long road to respectability 2Health News:IntelliDOT Bedside Medication Administration(TM) Goes Live at 55th Hospital 2Health News:IntelliDOT Bedside Medication Administration(TM) Goes Live at 55th Hospital 3Health News:IntelliDOT Bedside Medication Administration(TM) Goes Live at 55th Hospital 4Health News:Region's Hospitals Engage in New Patient-Safety Efforts to Further Reduce Infections, Errors, and Improve Quality of Care 2Health News:Region's Hospitals Engage in New Patient-Safety Efforts to Further Reduce Infections, Errors, and Improve Quality of Care 3Health News:Heart failure linked to cognitive impairment 2Health News:Milwaukee Journal Sentinel Wins First Health Journalism Award from Foundation for Informed Medical Decision Making 2Health News:Milwaukee Journal Sentinel Wins First Health Journalism Award from Foundation for Informed Medical Decision Making 3
(Date:3/16/2010)... 2010 Rauland-Borg, the,leader in ... a global,provider of scalable Active RFID/RTLS based ... industry announce the integration of Elpas RTLS,technology ... This joint collaboration,between Visonic Technologies and Rauland-Borg ... throughout the hospital to room and,sub-room level ...
(Date:3/16/2010)... system. The innovative system enables hospitals to more effectively combat Hospital-Acquired Infections (HAIs) by dramatically increasing hand hygiene compliance among healthcare workers.   , ... ... ... ... HAIs waste ...
(Date:3/16/2010)... March 16 SpineMark CRO ... based SpineMark Corporation, recently signed an agreement ... based spinal medical device manufacturer, to provide contract ... trial, a 3rd generation lumbar total disc replacement ... the lumbar spine.  SpineMark CRO Management provides site ...
Breaking Medicine Technology:Rauland-Borg and Visonic Technologies Collaboration Brings Enhanced RTLS Functionality to the Responder 5(R) Nurse Call System 2Rauland-Borg and Visonic Technologies Collaboration Brings Enhanced RTLS Functionality to the Responder 5(R) Nurse Call System 3Rauland-Borg and Visonic Technologies Collaboration Brings Enhanced RTLS Functionality to the Responder 5(R) Nurse Call System 4BioVigil Releases Second-Generation Hand Hygiene Monitoring System 2BioVigil Releases Second-Generation Hand Hygiene Monitoring System 3BioVigil Releases Second-Generation Hand Hygiene Monitoring System 4San Diego Based CRO Signs Agreement With UK Based Spinal Device Manufacturer 2San Diego Based CRO Signs Agreement With UK Based Spinal Device Manufacturer 3Verathon Inc Appoints Kendall Stever as Chief Financial Officer 50131 1Verathon Inc Appoints Kendall Stever as Chief Financial Officer 50131 2FDA Seizes All Drugs From Generics Maker 50126 1FDA Seizes All Drugs From Generics Maker 50126 2Cancer Researchers Link DICER1 Gene Mutation to Rare Childhood Cancer 50122 1Cancer Researchers Link DICER1 Gene Mutation to Rare Childhood Cancer 50122 2Cancer Researchers Link DICER1 Gene Mutation to Rare Childhood Cancer 50122 3
... Compound Currently in ... LA JOLLA, Calif., Aug. 27 TorreyPines,Therapeutics, Inc. (Nasdaq: ... a,Phase I multiple dose clinical trial to evaluate the ... injection to,healthy male and female volunteers once-daily for four ...
... Proprietary Artificial, Intelligence-Based Drug Discovery Platform and Novel Drug Candidates ... ... -Initial Compounds Demonstrate Promising In Vitro Activity Against, ... Aug. 27 Upstream Biosciences,Inc. (OTC Bulletin Board: UPBS) today announced ...
Other Medicine Technology:TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel 2TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel 3TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel 4Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 2Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 3Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 4Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 5Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 6Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 7
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: